Aragon Pharmaceuticals Receives $49,999,988 Series D Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fe7be6dc-b304-4064-9684-2cd848d3c768&Preview=1 -
Date
9/26/2012 -
Company Name
Aragon Pharmaceuticals -
Mailing Address
12780 El Camino Real San Diego, CA 92130 -
Company Description
Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. -
Website
http://www.aragonpharmaceuticals.com -
Transaction Type
Venture Equity -
Transaction Amount
$49,999,988 -
Transaction Round
Series D -
Proceeds Purposes
This financing combined with our raise earlier this year provides Aragon with the resources to advance our pipeline, including ARN-509 for which we just recently announced promising Phase II results in prostate cancer patients. -
M&A Terms
-
Venture Investor
venBio -
Venture Investor
Topspin Partners -
Venture Investor
OrbiMed Advisors -
Venture Investor
Aisling Capital -
Venture Investor
The Column Group
